Guidelines for the management of basal cell carcinoma

@article{Telfer2008GuidelinesFT,
  title={Guidelines for the management of basal cell carcinoma},
  author={N R Telfer and Graham B. Colver and Colin A Morton},
  journal={British Journal of Dermatology},
  year={2008},
  volume={159}
}
This article represents a planned regular updating of the previous British Association of Dermatologists guidelines for the management of basal cell carcinoma. These guidelines present evidence‐based guidance for treatment, with identification of the strength of evidence available at the time of preparation of the guidelines, and a brief overview of epidemiological aspects, diagnosis and investigation. 
Surgical treatment of basal cell carcinoma: a case series on factors influencing the risk of an incomplete primary excision
TLDR
Surgical excision is vital to minimize risk of recurrence of basal cell carcinoma and studies on occurrence of incomplete excision have given diverse results and seldom include large populations from a dermatological setting.
British Association of Dermatologists guidelines for the management of adults with basal cell carcinoma 2021 *
TLDR
The document aims to offer an appraisal of all relevant literature up to 24th January 2020 focusing on any key developments address important, practical clinical questions relating to the primary guideline objective.
S2k Guidelines for Cutaneous Basal Cell Carcinoma – Part 2: Treatment, Prevention and Follow‐up
  • B. Lang, P. Balermpas, S. Grabbe
  • Medicine
    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
  • 2019
TLDR
The German S2k guidelines were updated following a systematic literature search and with the participation of all professional societies and associations involved in the management of the disease.
Guidelines of care for the management of basal cell carcinoma.
Basal cell carcinoma of the skin (part 2): diagnosis, prognosis and management.
TLDR
This review aims to present a concise and updated overview of BCC histopathology and clinical presentation and progression, and some of the new promising agents.
Evaluation of the appropriate surgical margin for pigmented basal cell carcinoma according to the risk factors for recurrence: a single‐institute retrospective study in Japan
TLDR
Recommendations for the complete removal of BCC are based on studies of Caucasian non-pigmented BCCs, in contrast, most Asian BCCs are pigmented and relatively demarcated.
An Unusual Location of Basal Cell Carcinoma: Two Case Reports
TLDR
The aim of the report is to show that this prevalant cutaneous malignancy can be encountered in rare/unusual areas.
Management of basal cell carcinoma
The incidence of this highly common skin cancer is rising. Suneeta Kochhar explains how to treat it
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 323 REFERENCES
Guidelines for the management of basal cell carcinoma. British Association of Dermatologists.
These guidelines on the management of basal cell carcinoma have been prepared for dermatologists on behalf of the British Association of Dermatologists. They present evidence-based guidance for
Follow‐up of basal cell carcinomas: an audit of current practice
TLDR
All patients are reviewed for 2 years after surgical excision of a low‐risk primary BCC at the skin tumour clinic in the dermatology department, the Royal Hospitals, Belfast.
Guidelines: the management of basal cell carcinoma.
  • W. Sterry
  • Medicine
    European journal of dermatology : EJD
  • 2006
TLDR
This guideline represents an evidence-based guidance for treatment, with identification of the strength of evidence available at the time of preparation of the guideline, and a brief overview of epidemiological aspects and clinical management of patients with BCC.
Superficial radiotherapy for patients with basal cell carcinoma
TLDR
Recurrence rates among patients with BCC after superficial radiotherapy as well as Bcl‐2 and p53 expression levels stratified by BCC subtype are reported.
Recurrent basal cell carcinoma. A review concerning the incidence, behavior, and management of recurrent basal cell carcinoma, with emphasis on the incompletely excised lesion.
Although controversial among dermatologists and surgeons, the conclusion based on this review is that basal cell carcinomas, with marginal histologic involvement, should be reexcised. When the
Basal cell carcinoma follow‐up practices by dermatologists: a national survey
TLDR
Long‐term hospital‐based follow-up of all patients with basal cell carcinoma at risk of recurrence of that BCC would put large strains on the U.K. health service.
Histological evolution of recurrent basal cell carcinoma and therapeutic implications for incompletely excised lesions
TLDR
It is proposed that the management of incompletely excised recurrent basal cell carcinomas should depend on their histological appearance, and that nonaggressive recurrent BCCs may not require re‐excision.
Incomplete excision of basal cell carcinomas: A retrospective audit
TLDR
The study aims to determine the rate of incomplete excision of BCC at a major cancer centre.
Positive surgical excision margins of a basal cell carcinoma.
  • W. Grabski, S. Salasche
  • Medicine
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]
  • 1998
TLDR
The best plan is to individualize the decision-making process based on the available variables, the patient's age and health, and a "guided," but informed decision by the patient.
Basal cell carcinoma
TLDR
It is reported that presentation with a cluster of BCC is associated with an inherited predisposition to develop many additional lesions suggesting clustering is a critical event.
...
1
2
3
4
5
...